Lydia Campos - Concepedia

Author

Lydia Campos

Centre Hospitalier Universitaire de Saint-Étienne ORCID

Also Known As

Campos, Lydia, L Campos, L. CAMPOS, L. Campos, L. Ontiveros Campos, L.M. Campos, LEIDE DAIANA DOS SANTOS CAMPOS, Livia Mizuki de Campos, Luis M. Campos Villarino, Lydia Campos

169

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Saint-Étienne Inserm Hôpital Edouard Herriot Hôpital Nord Institut National de la Transfusion Sanguine

About

Lydia Campos is an author at Centre Hospitalier Universitaire de Saint-Étienne specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1K
2	Cell Biology	15	18	664
3	Immunology	11	12	525
4	Health Sciences	7	7	185
5	Blood Transplantation	1	1	38

Lydia Campos

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy Lydia Campos, JP Rouault, Odile Sabido, Blood	1993	777
Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments] Lydia Campos, Denis Guyotat, E Archimbaud, Blood	1992	495
Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells Lydia Campos, Odile Sabido, JP Rouault, Blood	1994	161
Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy Lydia Campos, Denis Guyotat, E Archimbaud, British Journal of Haematology	1989	147
Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia Xavier Thomas, Lydia Campos, Christiane Mounier, Leukemia Research Hematological MalignancyHeat-shock ProteinsMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaHematology	2005	131
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, Blood Advances	2019	120
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia Claude Boucheix, B. David, Catherine Sebban, Blood	1994	117
Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint E Archimbaud, C Charrin, J.P. Magaud, Leukemia Hematological MalignancyChromatinMixed-phenotype Acute LeukemiaGeneticsHematology	1998	111
Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia Claude Boucheix, B. David, Catherine Sebban, Blood	1994	99
Immunological classification of acute myeloblastic leukemias: relevance to patient outcome Olivier Casasnovas, F. K. ra Slimane, Richard Garand, Leukemia Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyHematology	2003	98

Page 1